PMID: 7023655Sep 15, 1981Paper

Polyvalent pneumococcal immunization of patients with plasma cell dyscrasias

Cancer
R A ShildtP Giolma

Abstract

Thirteen patients with plasma cell dyscrasias and 27 healthy adults were immunized with polyvalent pneumococcal vaccine. Antibody responses were determined by radioimmunoassay. Patients with plasma cell disorders had significantly lower preimmunization and postimmunization antibody titers compared with those of the controls (P-0.01 abd 0.008, respectively). Even though the overall response in myeloma patients was poor, occasional rises in antibody titers occurred. Immunizing myeloma patients with the pneumococcal vaccine is recommended.

References

Aug 31, 1978·The New England Journal of Medicine·G R SiberG Schiffman
Jun 1, 1979·Annals of Internal Medicine·D R MinorL S McIntosh
Dec 21, 1967·The New England Journal of Medicine·S E SalmonA Schilling
Feb 1, 1953·Journal of Clinical Pathology·J MARKS
Dec 1, 1954·Annals of Internal Medicine·H H ZINNEMAN, W H HALL
Jan 6, 1955·The New England Journal of Medicine·H A LAWSONR W PHILIPS
Dec 1, 1964·The Journal of Clinical Investigation·L CONE, J W UHR

❮ Previous
Next ❯

Citations

Mar 6, 2010·Cancer Chemotherapy and Pharmacology·Ajithkumar PuthillathMarwan G Fakih
Jul 20, 2005·Best Practice & Research. Clinical Haematology·Joan Bladé, Laura Rosiñol

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.